Buy Crypto Markets Spot FuturesZEC Earn Event Centre Rewards Hub

Inovio Pharmaceuticals, Inc. (INO)

NASDAQ

$1.44

$+0.03

(+1.77%)

Pre-Market

Inovio Pharmaceuticals, Inc. (INO) Live Price Chart

Last updated: ⁦2026-09-09 09:50:00⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

Inovio Pharmaceuticals, Inc. (INO) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $1.44, with a market capitalisation of $147.86M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.56 to $2.98. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$147.86M
Open	$1.41
Day's High	$405.48
Day's Low	$0.56
Previous Close	$1.42
Volume	1.78K
Average Volume	3.48M
P/E Ratio	--
52-Week High	$2.98
52-Week Low	$0.56
Dividend Yield	--
Earnings Date	--

Inovio Pharmaceuticals, Inc. (INO) Pre-Market Stock Price

Inovio Pharmaceuticals, Inc. (INO) is trading at $1.44 in pre-market trading as of 2026-09-09 09:49:00, up 1.06% ($0.02) from the previous close of $1.42

Pre-market trading shows how investors are pricing INO before the regular session opens. The current pre-market price is above the previous close, indicating positive early trading sentiment.

Inovio Pharmaceuticals, Inc. (INO) 7-Day Stock Price Change

Over the past seven days, Inovio Pharmaceuticals, Inc. (INO) moved from $1.29 to $1.44, representing a gain of 11.24% ($0.15).

The stock traded between $1.22 and $1.45 during the period. The latest price is near the upper end of the 7-day range, indicating strong upward.

The average daily volume was 3.57 million shares, down versus the previous seven-day period, indicating lower trading activity.

INO 52-Week Price Position

Position in Range: 36.1%

52W Low$0.56

52W High$2.98

INO is currently trading at $1.44, placing it 36.1% of the way from its 52-week low of $0.56 to its 52-week high of $2.98. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Inovio Pharmaceuticals, Inc. (INO)?

Inovio Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from diseases associated with human papillomavirus (HPV), cancer and infectious diseases. INOVIO's platform harnesses the power of in vivo protein production, featuring optimized design and delivery of DNA medicines that teach the body to manufacture its own disease-fighting tools. Its candidate is INO-3107 for the treatment of recurrent respiratory papillomatosis (RRP), a chronic, rare and debilitating disease of the respiratory tract caused by HPV infection. In its completed Phase 1/2 clinical trial of INO-3107 for the treatment of HPV-6 and HPV-11-associated RRP.

Inovio Pharmaceuticals, Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	112
Exchange	NASDAQ
Company Website	https://www.inovio.com

How to Buy Inovio Pharmaceuticals, Inc. (INO) Stock on MEXC

Eligible investors can buy real shares of Inovio Pharmaceuticals, Inc. (INO) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licenced broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for INO and Place Your Order

Open the RealStocks trading page and search for INO. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Inovio Pharmaceuticals, Inc. (INO) share price today?

Inovio Pharmaceuticals, Inc. (INO) is currently trading at $ 1.44, up 1.06% ($0.02) from the previous close of $ 1.42. Intraday prices update in real time during regular trading hours.

2.Is INO stock going up or down today?

As of 2026-09-09 09:49:00, INO is trading at $ 1.44, up 1.06% ($0.02) from its previous close of $ 1.42. The stock has traded between $ 0.56 and $ 405.48 during today’s regular session. Past price movements do not guarantee future results.

3.What is INO pre-market price?

As of 2026-09-09 09:49:00, INO is trading at $ 1.44 in pre-market trading, up 1.06% ($0.02) from the previous close of $ 1.42. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is INO after-hours price?

As of 2026-09-09 09:49:00, INO is trading at $ 1.41 in after-hours trading, down 0.63% ($0.01) from the regular-session close of $ 1.42. After-hours prices may differ from the regular session's opening price due to lower liquidity and wider bid-ask spreads.

5.Is INO stock trading now?

INO trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does INO sit relative to its 52-week high and low?

Over the past 52 weeks, INO has traded between a low of $ 0.56 and a high of $ 2.98. At $ 1.44, the stock is positioned 36.1% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Inovio Pharmaceuticals, Inc. in?

Inovio Pharmaceuticals, Inc. (INO) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Inovio Pharmaceuticals, Inc.'s market capitalisation and where is it listed?

Inovio Pharmaceuticals, Inc. is listed on the NASDAQ exchange with a market capitalisation of $ 147.86M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is INO valued in terms of P/E ratio and EPS?

INO trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -0.65. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Inovio Pharmaceuticals, Inc. pay a dividend?

Inovio Pharmaceuticals, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.